CoChat
Sign Up
Cited by 428Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatmentsCancer-related cognitive impairment studies

The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.

Subjective cognitive decline and rates of incident Alzheimer's disease and non-Alzheimer's disease dementia

Open access
Slot, Rosalinde E.R., Sikkes, Sietske A.M., Berkhof, Johannes, Brodaty, Henry, Buckley, Rachel, Cavedo, Enrica, Dardiotis, Efthimios, Guillo‐Benarous, Francoise, Hampel, Harald, Kochan, Nicole A., Lista, Simone, Luck, Tobias, Maruff, Paul, Molinuevo, José Luis, Kornhuber, Johannes, Reisberg, Barry, Riedel‐Heller, Steffi G., Risacher, Shannon L., Roehr, Susanne, Sachdev, Perminder S., Scarmeas, Nikolaos, Scheltens, Philip, Shulman, Melanie B., Saykin, Andrew J., Verfaillie, Sander C.J., Visser, Pieter Jelle, Vos, Stephanie J.B., Wagner, Michael, Wolfsgruber, Steffen, Jessen, Frank, the Alzheimer's Disease Neuroimaging Initiative, the DESCRIPA working group, the INSIGHT‐preAD study group, SCD‐I working group, van der Flier, Wiesje M.·2019·Alzheimer's & Dementia
DOI 10.1016/j.jalz.2018.10.003PMC PMC6465066
Open this paper in CoChat — free accountOpen PDF

Abstract

INTRODUCTION: In this multicenter study on subjective cognitive decline (SCD) in community-based and memory clinic settings, we assessed the (1) incidence of Alzheimer's disease (AD) and non-AD dementia and (2) determinants of progression to dementia. METHODS: Eleven cohorts provided 2978 participants with SCD and 1391 controls. We estimated dementia incidence and identified risk factors using Cox proportional hazards models. RESULTS: In SCD, incidence of dementia was 17.7 (95% Poisson confidence interval 15.2-20.3)/1000 person-years (AD: 11.5 [9.6-13.7], non-AD: 6.1 [4.7-7.7]), compared with 14.2 (11.3-17.6) in controls (AD: 10.1 [7.7-13.0], non-AD: 4.1 [2.6-6.0]). The risk of dementia was strongly increased in SCD in a memory clinic setting but less so in a community-based setting. In addition, higher age (hazard ratio 1.1 [95% confidence interval 1.1-1.1]), lower Mini-Mental State Examination (0.7 [0.66-0.8]), and apolipoprotein E ε4 (1.8 [1.3-2.5]) increased the risk of dementia. DISCUSSION: SCD can precede both AD and non-AD dementia. Despite their younger age, individuals with SCD in a memory clinic setting have a higher risk of dementia than those in community-based cohorts.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jalz.2018.10.003

Cites

61 of 61 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1. Flowchart of participant selection. Overview of inclusion of participants. Abbreviations: MCI, mild cognitive impairment; SCD, subjective cognitive decline.
Fig. 1. Flowchart of participant selection. Overview of inclusion of participants. Abbreviations: MCI, mild cognitive impairment; SCD, subjective cognitive decline.CC BY-NC-ND · PubMed Central
Fig. 2. Type of dementia diagnosis in memory clinic and community settings. Dementia diagnoses per type of recruitment setting. Total number of dementia diagnoses: memory clinic n = 107, community n = 87. Results are represented as N (%).
Fig. 2. Type of dementia diagnosis in memory clinic and community settings. Dementia diagnoses per type of recruitment setting. Total number of dementia diagnoses: memory clinic n = 107, community n = 87. Results are represented as N (%).CC BY-NC-ND · PubMed Central
Fig. 3. Incidence rates of dementia and AD and non-AD dementia. (A) Incidence rates of dementia per decade in individuals with SCD and controls. (B) Incidence rates of AD and non-AD dementia per decade. Results are presented as incidence rates per 1000 person-years (95% Poisson confidence intervals) per decade. Abbreviations: AD, Alzheimer’s disease; CI, confidence interval; SCD, subjective cognitive decline.
Fig. 3. Incidence rates of dementia and AD and non-AD dementia. (A) Incidence rates of dementia per decade in individuals with SCD and controls. (B) Incidence rates of AD and non-AD dementia per decade. Results are presented as incidence rates per 1000 person-years (95% Poisson confidence intervals) per decade. Abbreviations: AD, Alzheimer’s disease; CI, confidence interval; SCD, subjective cognitive decline.CC BY-NC-ND · PubMed Central
Fig. 4. Kaplan-Meier curves of cumulative risk of dementia in controls and individuals with subjective cognitive decline in memory clinic and community cohorts. Kaplan-Meier curves of the cumulative risk of progression to dementia per decade, stratified for recruitment setting.
Fig. 4. Kaplan-Meier curves of cumulative risk of dementia in controls and individuals with subjective cognitive decline in memory clinic and community cohorts. Kaplan-Meier curves of the cumulative risk of progression to dementia per decade, stratified for recruitment setting.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 61 references

Cited by

Sorted by citations

Items 301–400 of 428

Related

See all

Metadata

Authors
Slot, R. E. R., Sikkes, S. A. M., Berkhof, J., Brodaty, H., Buckley, R., Cavedo, E., Dardiotis, E., Guillo‐Benarous, F., Hampel, H., Kochan, N. A., Lista, S., Luck, T., Maruff, P., Molinuevo, J. L., Kornhuber, J., Reisberg, B., Riedel‐Heller, S. G., Risacher, S. L., Roehr, S., Sachdev, P. S., Scarmeas, N., Scheltens, P., Shulman, M. B., Saykin, A. J., Verfaillie, S. C. J., Visser, P. J., Vos, S. J. B., Wagner, M., Wolfsgruber, S., Jessen, F., Initiative, T. A. D. N., the DESCRIPA working group, the INSIGHT‐preAD study group, SCD‐I working group, & van der Flier, W. M.
Affiliations
  • Amsterdam Neuroscience (NL)
  • Amsterdam University Medical Centers (NL)
  • UNSW Sydney (AU)
  • Harvard University (US)
  • Centre National de la Recherche Scientifique (FR)
  • University of Thessaly (GR)
  • NYU Langone Health (US)
  • Nordhausen University of Applied Sciences (DE)
  • Florey Institute of Neuroscience and Mental Health (AU)
  • Neurology Department Hospital Clínic i Universitari‐IDIBAPS and BarcelonaBeta Brain Research Center Pasqual Maragall Foundation Barcelona Spain
  • Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
  • Institute of Social Medicine Occupational Health and Public Health (ISAP) Faculty of Medicine University of Leipzig Leipzig Germany
  • Indiana University Indianapolis (US)
  • National and Kapodistrian University of Athens (GR)
  • Maastricht University (NL)
  • University of Bonn (DE)
  • University of Cologne (DE)
  • Alzheimer Center Amsterdam Department of Neurology Amsterdam Neuroscience Vrije Universiteit Amsterdam Amsterdam UMC Amsterdam the Netherlands
Corresponding author
the Alzheimer's Disease Neuroimaging Initiative
ORCID
Venue
Alzheimer's & Dementia
Publisher
Wiley
Published
2018-12-13
Volume
15
Issue
3
Pages
465-476
ISSN
  • 1552-5260 (ISSN-L)
  • 1552-5279
DOI
10.1016/j.jalz.2018.10.003
PMC
PMC6465066
OpenAlex
W2904079367
Cited by
428
References
61
Citations by year
2026: 39 · 2025: 55 · 2024: 68 · 2023: 65 · 2022: 65 · 2021: 54 · 2020: 62 · 2019: 17 · 2018: 3
FWCI
26.57
Type
journal article
Language
en
Open access
Licence
Locations
  • Alzheimer s & Dementia (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • Pure Amsterdam UMC (publishedVersion, cc-by)
  • VU Research Portal (publishedVersion, other-oa)
  • Europe PMC (PubMed Central) (acceptedVersion, cc-by-nc-nd)
  • PubMed Central (acceptedVersion, cc-by-nc-nd)
  • Minerva Access (University of Melbourne) (submittedVersion, cc-by-nc-nd)
  • HAL (submittedVersion, cc-by-nc-nd)
  • Research Publications (Maastricht University) (submittedVersion, cc-by-nc-nd)
  • University of Thessaly Institutional Repository (University of Thessaly) (submittedVersion)
  • CINECA IRIS Institutial Research Information System (University of Genoa) (submittedVersion, other-oa)
  • Massey Research Online (Massey University) (submittedVersion)
  • Amsterdam UMC (VU Amsterdam) - Institutional Repository (submittedVersion, other-oa)
  • IUScholarWorks (Indiana University) (submittedVersion)
  • Purdue University Indianapolis (Indiana University) (submittedVersion)
  • Research Publications (Maastricht University) (submittedVersion, other-oa)
  • Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
Funders
  • ZonMw
  • Alzheimer's Association (IIRG-09-133014)
  • Centre Hospitalier Universitaire de Bordeaux (CIC EC7)
  • AXA Research Fund
  • U.S. Department of Health and Human Services (AG08051, AG03051)
  • National Institute on Aging (P30 AG010133, R01 AG019771, K01 AG049050)
  • U.S. Department of Defense (W81XWH-12-2-0012)
  • National Institute of Biomedical Imaging and Bioengineering
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Oncology › Cancer-related cognitive impairment studies
Keywords
subjective cognitive decline, Alzheimer's disease
MeSH terms
Aged, Aged, 80 and over, Dementia, Female, Humans, Male, Middle Aged, Risk Factors, Self Concept, Cohort Studies, Incidence, Disease Progression, Diagnostic Self Evaluation, Cognitive Dysfunction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review